<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Yestino - The Signal · AbbVie</title><link>https://yestino.com/entities/abbvie-5ee503</link><description>Every event involving AbbVie</description><language>en</language><atom:link href="https://yestino.com/entities/abbvie-5ee503/feed.xml" rel="self" type="application/rss+xml"/><item><title>ADARx Pharmaceuticals raised $446 million in a biotech IPO backed by AbbVie</title><link>https://yestino.com/events/adarx-pharmaceuticals-raised-446-million-in-a-biotech-ipo-ba-caebe6</link><guid isPermaLink="true">https://yestino.com/events/adarx-pharmaceuticals-raised-446-million-in-a-biotech-ipo-ba-caebe6</guid><pubDate>Fri, 25 Sep 2026 14:10:31 GMT</pubDate><description>The San Diego RNA drug developer sold 26.3 million shares at $17 apiece, with AbbVie investing up to $100 million in a concurrent private placement
Sources: Quartz</description></item></channel></rss>